NCT00440947 - Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection | Biotech Hunter

Enrollment

515

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Infection, Human Immunodeficiency Virus IHIV Infection

Interventions

DRUG

Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r)

Abacavir (ABC)/lamivudine (3TC) FDC + atazanavir (ATV)+ ritoanvir (/r) for 36weeks followed by ABC/3TC + ATV + /r for 48wks followed by optional treatment extension for 60 weeks on the same regimen

DRUG

Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)

Abacavir (ABC)/lamivudine (3TC) FDC + atazanavir (ATV) + ritonavir (/r) for 36 weeks followed by ABC/3TC + ATV for 48wks followed by optional treatment extension for 60 weeks on the same regimen

Trial Locations (72)

2906

GSK Investigational Site, Providence

10011

GSK Investigational Site, New York

10595

GSK Investigational Site, Valhalla

19104

GSK Investigational Site, Philadelphia

19107

GSK Investigational Site, Philadelphia

20007

GSK Investigational Site, Washington D.C.

20009

GSK Investigational Site, Washington D.C.

20036

GSK Investigational Site, Washington D.C.

20037

GSK Investigational Site, Washington D.C.

21201

GSK Investigational Site, Baltimore

22003

GSK Investigational Site, Annandale

23507

GSK Investigational Site, Norfolk

27834

GSK Investigational Site, Greenville

28209

GSK Investigational Site, Charlotte

30033

GSK Investigational Site, Decatur

30308

GSK Investigational Site, Atlanta

30309

GSK Investigational Site, Atlanta

30339

GSK Investigational Site, Atlanta

30912

GSK Investigational Site, Augusta

32803

GSK Investigational Site, Orlando

33136

GSK Investigational Site, Miami

33306

GSK Investigational Site, Fort Lauderdale

33308

GSK Investigational Site, Fort Lauderdale

33316

GSK Investigational Site, Fort Lauderdale

33317

GSK Investigational Site, Plantation

33602

GSK Investigational Site, Tampa

33607

GSK Investigational Site, Tampa

34243

GSK Investigational Site, Sarasota

34982

GSK Investigational Site, Ft. Pierce

40536

GSK Investigational Site, Lexington

43614

GSK Investigational Site, Toledo

44304

GSK Investigational Site, Akron

48202

GSK Investigational Site, Detroit

55404

GSK Investigational Site, Minneapolis

55415

GSK Investigational Site, Minneapolis

60153

GSK Investigational Site, Maywood

60637

GSK Investigational Site, Chicago

60657

GSK Investigational Site, Chicago

63110

GSK Investigational Site, St Louis

75204

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

75605

GSK Investigational Site, Longview

76104

GSK Investigational Site, Fort Worth

77004

GSK Investigational Site, Houston

77030

GSK Investigational Site, Houston

77057

GSK Investigational Site, Houston

77555

GSK Investigational Site, Galveston

78705

GSK Investigational Site, Austin

79925

GSK Investigational Site, El Paso

80220

GSK Investigational Site, Denver

85012

GSK Investigational Site, Phoenix

90022

GSK Investigational Site, Los Angeles

90033

GSK Investigational Site, Los Angeles

90813

GSK Investigational Site, Long Beach

92663

GSK Investigational Site, Newport Beach

94609

GSK Investigational Site, Oakland

06033

GSK Investigational Site, Glastonbury

02115

GSK Investigational Site, Boston

02215

GSK Investigational Site, Boston

08844

GSK Investigational Site, Hillsborough

07102

GSK Investigational Site, Newark

08244

GSK Investigational Site, Somers Point

M4N 3M5

GSK Investigational Site, Toronto

M5B 1L6

GSK Investigational Site, Toronto

M5G 2N2

GSK Investigational Site, Toronto

H2L 4P9

GSK Investigational Site, Montreal

H2L 5B1

GSK Investigational Site, Montreal

H2X 2P4

GSK Investigational Site, Montreal

00717

GSK Investigational Site, Ponce

00731

GSK Investigational Site, Ponce

00909-1711

GSK Investigational Site, San Juan

00910

GSK Investigational Site, San Juan